-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

711.O1.6 711. Cell Collection and Processing I

Symposia: Cell Collection and Processing Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, clinical trials, Lymphoid Leukemias, ALL, Translational Research, Lymphomas, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Clinical Research, hematopoiesis, T Cell lymphoma, drug development, Diseases, cell expansion, Therapies, clinical procedures, immunology, Immunotherapy, real-world evidence, Lymphoid Malignancies, registries, Biological Processes, emerging technologies, Natural Killer (NK) Cell Therapies, Technology and Procedures, gene editing, Transplantation
Sunday, December 11, 2022: 4:30 PM-6:00 PM
220-222 (Ernest N. Morial Convention Center)
Moderators:
Renato Luiz Guerino-Cunha, M.D - Ph.D., Grupo Oncoclínicas and Camelia Iancu-Rubin, PhD, MSc, Icahn School of Medicine at Mount Sinai
Disclosures:
Guerino-Cunha: Kite: Speakers Bureau; Janssen: Speakers Bureau; Novartis: Speakers Bureau.
4:30 PM

Denis-Claude Roy, MD1,2, Jean-Sébastien Delisle, MD, PhD1,3, Imran Ahmad, MD1,2, Brian Leber, MD4, Félix Couture, MD5*, Stephanie Thiant1*, Natasha Kekre, MD, FRCPC6, Radia Sidi Boumedine, MSc1*, Cédric Carli, PhD1*, Ann Brasey, PhD.7*, Nadia M. Bambace, MD1,2, Léa Bernard, MD1,2, Sandra Cohen, MD1,2, Thomas L. Kiss, MD1,3, Jean Roy, MD1,2, Guy Sauvageau, MD, PhD1,8, Olivier Veilleux, MD1,3, Claude Perreault, MD2,8, Lambert Busque, MD1,2 and Silvy Lachance, MD1,2

1University Institute for Hematology-Oncology and Cell Therapy, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
2Department of Medicine, Université de Montréal, Montreal, QC, Canada
3Département de Médecine, Université de Montréal, Montreal, QC, Canada
4Department of Medicine, Division of Hematology, Juravinski Cancer Centre, Hamilton, ON, Canada
5Division of Hematology, Oncology and Transplantation, CHU de Québec, Quebec City, QC, Canada
6Hematology, The Ottawa Hospital, Ottawa, ON, Canada
7C3i Center, CIUSSS-de-l'Est-de-l'Île-de-Montreal, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
8Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada

4:45 PM

Ruchi P. Patel, MS1, Guido Ghilardi, MD1*, Patrizia Porazzi, PhD1*, Steven Yang, MD, PhD2*, Dean Qian, MS2*, Raymone Pajarillo, MS1*, Michael Wang1*, Yunlin Zhang, MS3*, Stephen J. Schuster, MD4, Stefan K. Barta, MD5, Aditya Nimmagadda, PMP2*, Adam Snook, PhD2*, Nicholas A. Siciliano, PhD2* and Marco Ruella, MD1

1Division of Hematology-Oncology and Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
2viTToria biotherapeutics, Philadelphia, PA
3Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia
4University of Pennsylvania, Philadelphia, PA
5Department of Medicine, University of Pennsylvania, Philadelphia, PA

5:00 PM

Christina Chaivorapol, PhD*, Pascal Beauchesne*, Rowena De Jesus*, William E Dowdle*, Xiaoyu Chen*, Alison Bayley*, Yunjiang Qiu*, Andrew Birnberg*, Yu Zheng*, Antonino Montalbano*, Angela Liu*, Misbah Zafar*, Karl Manner*, Ramya Ankala*, Eleonore Tham, PhD*, Heer Shah*, Ben Lam*, Jaclyn Lock*, Lindong Weng*, Kate Watts*, Amanda Valdiosera*, Kimberly Davis*, Lei Wang*, Divy Kangeyan, PhD*, Nicolas Devos*, Athena Wong*, Jason Lih* and Edward J Rebar, PhD*

Sana Biotechnology, South San Francisco

5:15 PM

Tomoyasu Jo, MD, PhD1,2*, Yasuyuki Arai, MD, PhD, FACP1,2, Satoshi Yoshihara, MD, PhD3,4*, Minoru Kojima5*, Junko Ikemoto4*, Tomoe Uemura6*, Keita Iwaki7*, Noboru Yonetani, MD8*, Shin-ichiro Fujiwara, MD, PhD9*, Masaki Ri10*, Kaoru Kahata, MD, PhD11*, Tokiko Nagamura-Inoue, MD, PhD12, Minami Yamada-Fujiwara, MD, PhD7,13* and Ryuji Tanosaki, MD, PhD14

1Department of Hematology and Oncology, Kyoto University Hospital, Kyoto, Japan
2Center for Research and Application of Cellular Therapy, Kyoto University Hospital, Kyoto, Japan
3Department of Hematology, Hyogo Medical University Hospital, Nishinomiya, Japan
4Transfusion Medicine and Cell Therapy, Hyogo Medical University Hospital, Nishinomiya, Japan
5Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
6Center for Transfusion Medicine and Cell Therapy, Keio University Hospital, Tokyo, Japan
7Division of Blood Transfusion and Cell Processing, Tohoku University Hospital, Sendai, Japan
8Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
9Division of Cell Transplantation and Transfusion, Jichi Medical University, Shimotsuke, Japan
10Department of Hematology and Oncology, Nagoya City Univ. Grad. Sch. of Med. Sci., Nagoya, Japan
11Department of Hematology, Faculty of Medicine, Hokkaido University, Sapporo, Japan
12Department of Cell Processing and Transfusion, and IMSUT CORD, Research Hospital, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan
13Department of Hematology and Rheumatology, Tohoku University Hospital, Sendai, Japan
14Center for Transfusion Medicine and Cell Therapy, Keio University School of Medicine, Tokyo, Japan

5:30 PM

Sandra Cohen, MD1,2,3,4, Nadia M. Bambace, MD2,3,4, Imran Ahmad, MD4, Linda J. Burns, MD5, Jean Roy, MD6, Silvy Lachance, MD3, Léa Bernard, MD7, Jean-Sébastien Delisle, MD, PhD3, Denis-Claude Roy, MD3, Thomas L. Kiss, MD7, Olivier Veilleux, MD3, Mei-Jie Zhang, PhD5*, Xiao-Ying Tang, MPH5* and Guy Sauvageau, MD, PhD8,9,10

1University of Montreal and Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
2Division of Hematology-Oncology, CIUSSS de l'Est-de-l'Île-de-Montréal, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
3University Institute for Hematology-Oncology and Cell Therapy, Hopital Maisonneuve-Rosemont, Montreal, QC, Canada
4Department of Medicine, Université de Montréal, Montreal, QC, Canada
5Center for International Blood and Marrow Transplant Research, Milwaukee, WI
6Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, QC, Canada
7Division of Hematology and Medical Oncology, Stem Cell Transplant Program, Department of Medicine, University of Montreal and Maisonneuve-Rosemont Hospital, Montreal, QC, Canada
8Hôpital Maisonneuve-Rosemont, Département d’Hématologie-Oncologie, Montréal, QC, Canada
9Department of Medicine, Faculty of Medicine, Université de Montréal, Montréal, QC, Canada
10Institute for Research in Immunology and Cancer (IRIC), Université de Montréal, Montréal, QC, Canada

5:45 PM

Davide Bernareggi, PhD1*, Caryn Gonsalves, PhD1*, Max Schabla, PhD1*, Alejandra Garate-Carrilo, PhD1*, Mohammad El-Kalay, PhD1*, Dan S Kaufman, MD, PhD2, Robert Hollingsworth, PhD1* and Huang Zhu1*

1Shoreline Bioscience, San Diego
2Department of Medicine, Division of Regenerative Medicine, University of California San Diego, La Jolla, CA

*signifies non-member of ASH